413 related articles for article (PubMed ID: 29974668)
41. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
42. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.
Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B
Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
[TBL] [Abstract][Full Text] [Related]
44. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
45. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.
Zhang J; Luo A; Huang F; Gong T; Liu Z
Cancer Lett; 2020 Jan; 469():390-398. PubMed ID: 31730904
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
[TBL] [Abstract][Full Text] [Related]
47. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
[TBL] [Abstract][Full Text] [Related]
48. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial‑mesenchymal transition.
Xu G; Ou L; Liu Y; Wang X; Liu K; Li J; Li J; Wang S; Huang D; Zheng K; Wang S
Oncol Rep; 2020 Jul; 44(1):29-42. PubMed ID: 32627007
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
50. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM
Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035
[TBL] [Abstract][Full Text] [Related]
51. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
52. FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis.
Zhang J; Di S; Li M; Dong Y; Xie S; Gong T; Hu P; Jia Q; Fan B
Pathol Res Pract; 2023 Dec; 252():154945. PubMed ID: 37977035
[TBL] [Abstract][Full Text] [Related]
53. Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.
Guo D; Sheng K; Zhang Q; Li P; Sun H; Wang Y; Lyu X; Jia Y; Wang C; Wu J; Zhang X; Wang D; Sun Y; Huang S; Yu J; Zhang J
Cancer Lett; 2024 Apr; 587():216723. PubMed ID: 38342234
[TBL] [Abstract][Full Text] [Related]
54. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma.
Xin Z; Song X; Jiang B; Gongsun X; Song L; Qin Q; Wang Q; Shi M; Liu X
Thorac Cancer; 2018 Dec; 9(12):1687-1698. PubMed ID: 30267473
[TBL] [Abstract][Full Text] [Related]
55. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
[TBL] [Abstract][Full Text] [Related]
56. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
[TBL] [Abstract][Full Text] [Related]
57. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
58. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
59. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
60. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
